checkAd

    INVESTOR ALERT  4691  0 Kommentare Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses in Excess of $100,000 Investing in MiMedx Group, Inc. (MDXG) to Contact the Firm

    NEW YORK, NY--(Marketwired - February 25, 2015) - Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in MiMedx, Inc. ("MiMedx" or the "Company") (NASDAQ: MDXG) of the April 20, 2015 deadline to seek the role of lead plaintiff in a federal securities class action lawsuit filed against MiMedx and certain executives.

    A complaint has been filed in the Southern District of New York on behalf of all persons who purchased MiMedx securities from February 26, 2014 through December 31, 2014, inclusive (the "Class Period").

    The complaint alleges that the Company and its executives violated federal securities laws with respect to its disclosures concerning its business, operations, and prospects.

    Specifically, the action alleges that throughout the Class Period MiMedx failed to disclose that the Company was in violation of federal regulations by conducting improper marketing and sales practices.

    On December 31, 2014, MiMedx announced that it had received a subpoena from the Office of Inspector General of the Department of Health and Human Services regarding the Company's sales and marketing activities.

    Following this news, the Company's stock declined $1.79 per share, or over 15%, to close at $9.74 per share on January 2, 2015.

    Request more information now by clicking here: www.faruqilaw.com/MDXG. There is no cost or obligation to you.

    Take Action

    If you invested in MiMedx stock or options between February 26, 2014 and December 31, 2014 and would like to discuss your legal rights, visit www.faruqilaw.com/MDXG. You can also contact us by calling Richard Gonnello toll free at 877-247-4292 or at 212-983-9330 or by sending an e-mail to rgonnello@faruqilaw.com. Faruqi & Faruqi, LLP also encourages anyone with information regarding MiMedx's conduct to contact the firm, including whistleblowers, former employees, shareholders and others.

    Faruqi & Faruqi, LLP is a national law firm which represents investors and individuals in class action litigation. The firm is focused on providing exemplary legal services in complex litigation in the areas of securities, shareholder, antitrust and consumer litigation, throughout all phases of litigation. The firm has an experienced trial team which has achieved significant victories on behalf of the firm's clients. To keep track of the latest securities litigation news, follow us on Twitter at www.twitter.com/MergerActivity or on Facebook at www.facebook.com/FaruqiLaw.

    Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.

    FARUQI & FARUQI, LLP
    369 Lexington Avenue, 10th Floor
    New York, NY 10017
    Attn: Richard Gonnello, Esq.
    rgonnello@faruqilaw.com
    Telephone: (877) 247-4292 or (212) 983-9330




    Verfasst von Marketwired
    INVESTOR ALERT Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses in Excess of $100,000 Investing in MiMedx Group, Inc. (MDXG) to Contact the Firm NEW YORK, NY--(Marketwired - February 25, 2015) - Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in MiMedx, Inc. ("MiMedx" or the "Company") (NASDAQ: MDXG) of the April 20, 2015 deadline to seek the role of lead …